| Literature DB >> 20843820 |
Christopher I Li1, Nobuo Nishi, Jean A McDougall, Erin O Semmens, Hiromi Sugiyama, Midori Soda, Ritsu Sakata, Mikiko Hayashi, Fumiyoshi Kasagi, Akihiko Suyama, Kiyohiko Mabuchi, Scott Davis, Kazunori Kodama, Kenneth J Kopecky.
Abstract
Radiation exposure is related to risk of numerous types of cancer, but relatively little is known about its effect on risk of multiple primary cancers. Using follow-up data through 2002 from 77,752 Japanese atomic bomb survivors, we identified 14,048 participants diagnosed with a first primary cancer, of whom 1,088 were diagnosed with a second primary cancer. Relationships between radiation exposure and risks of first and second primary cancers were quantified using Poisson regression. There was a similar linear dose-response relationship between radiation exposure and risks of both first and second primary solid tumors [excess relative risk (ERR)/Gy = 0.65; 95% confidence interval (CI), 0.57-0.74 and ERR/Gy = 0.56; 95% CI, 0.33-0.80, respectively] and risk of both first and second primary leukemias (ERR/Gy = 2.65; 95% CI, 1.78-3.78 and ERR/Gy = 3.65; 95% CI, 0.96-10.70, respectively). Background incidence rates were higher for second solid cancers, compared with first solid cancers, until about age 70 years for men and 80 years for women (P < 0.0001), but radiation-related ERRs did not differ between first and second primary solid cancers (P = 0.70). Radiation dose was most strongly related to risk of solid tumors that are radiation-sensitive including second primary lung, colon, female breast, thyroid, and bladder cancers. Radiation exposure confers equally high relative risks of second primary cancers as first primary cancers. Radiation is a potent carcinogen and those with substantial exposures who are diagnosed with a first primary cancer should be carefully screened for second primary cancers, particularly for cancers that are radiation-sensitive. ©2010 AACR.Entities:
Mesh:
Year: 2010 PMID: 20843820 PMCID: PMC2941904 DOI: 10.1158/0008-5472.CAN-10-0276
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701